MITO2i (Mitochondrial Innovation Initiative)
ISI MITO2i partners with industry to pursue innovative research in mitochondrial gene risk
January 28, 2022
Mitochondrial Innovation Initiative (MITO2i) and the University of Toronto, alongside NertraMark Corp. and the MitoCanada Foundation have been selected by Mitacs Inc. to conduct research into mitochondrial genetics in neurodegenerative and neuropsychiatric diseases. Mitochondria are complex organelles providing crucial energy for our body's cells to work. This level of complexity requires sophisticated models and strong partnerships […]
MITO2i launched as Institutional Strategic Initiative
March 25, 2020
What MITO2i does: DEVELOPING AWARENESS, ALIGNMENT AND INTEGRATION IN MITOCHONDRIALHEALTH AND DISEASE The relationship between mitochondrial dysfunction and severe mitochondrial disease has long been known. More recent research has established links to a broad range of neurodegenerative and metabolic disorders. This is a game-changer. Unveiling how mitochondrial dysfunction is implicated in multiple diseases will transform medical diagnoses, technologies […]